Format

Send to

Choose Destination
PLoS Biol. 2013 Nov;11(11):e1001699. doi: 10.1371/journal.pbio.1001699. Epub 2013 Nov 5.

Reflections on the cost of "low-cost" whole genome sequencing: framing the health policy debate.

Author information

1
Health Law Institute, University of Alberta, Edmonton, Alberta, Canada.

Abstract

The cost of whole genome sequencing is dropping rapidly. There has been a great deal of enthusiasm about the potential for this technological advance to transform clinical care. Given the interest and significant investment in genomics, this seems an ideal time to consider what the evidence tells us about potential benefits and harms, particularly in the context of health care policy. The scale and pace of adoption of this powerful new technology should be driven by clinical need, clinical evidence, and a commitment to put patients at the centre of health care policy.

PMID:
24223516
PMCID:
PMC3818164
DOI:
10.1371/journal.pbio.1001699
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Public Library of Science Icon for PubMed Central
Loading ...
Support Center